190 related articles for article (PubMed ID: 21922300)
1. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
Agrawal A; Singh VK; Varma A; Sharma R
Indian J Pediatr; 2012 Apr; 79(4):488-93. PubMed ID: 21922300
[TBL] [Abstract][Full Text] [Related]
2. Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial.
Torgersen C; Dünser MW; Wenzel V; Jochberger S; Mayr V; Schmittinger CA; Lorenz I; Schmid S; Westphal M; Grander W; Luckner G
Intensive Care Med; 2010 Jan; 36(1):57-65. PubMed ID: 19756505
[TBL] [Abstract][Full Text] [Related]
3. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?
Dünser MW; Fries DR; Schobersberger W; Ulmer H; Wenzel V; Friesenecker B; Hasibeder WR; Mayr AJ
Anesth Analg; 2004 Jul; 99(1):201-206. PubMed ID: 15281530
[TBL] [Abstract][Full Text] [Related]
4. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
[TBL] [Abstract][Full Text] [Related]
5. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.
Dünser MW; Mayr AJ; Tür A; Pajk W; Barbara F; Knotzer H; Ulmer H; Hasibeder WR
Crit Care Med; 2003 May; 31(5):1394-8. PubMed ID: 12771608
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients.
Jerath N; Frndova H; McCrindle BW; Gurofsky R; Humpl T
Intensive Care Med; 2008 Jul; 34(7):1274-80. PubMed ID: 18350274
[TBL] [Abstract][Full Text] [Related]
7. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
[TBL] [Abstract][Full Text] [Related]
8. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis.
Dünser MW; Mayr AJ; Ulmer H; Ritsch N; Knotzer H; Pajk W; Luckner G; Mutz NJ; Hasibeder WR
Anesth Analg; 2001 Jul; 93(1):7-13. PubMed ID: 11429329
[TBL] [Abstract][Full Text] [Related]
9. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery.
Rosenzweig EB; Starc TJ; Chen JM; Cullinane S; Timchak DM; Gersony WM; Landry DW; Galantowicz ME
Circulation; 1999 Nov; 100(19 Suppl):II182-6. PubMed ID: 10567301
[TBL] [Abstract][Full Text] [Related]
10. [Arginine-vasopressin in septic and vasodilatorial shock].
Dünser MW; Hasibeder WR; Wenzel V; Meier-Hellmann A
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Nov; 41(11):716-9. PubMed ID: 17151983
[TBL] [Abstract][Full Text] [Related]
11. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
[TBL] [Abstract][Full Text] [Related]
12. Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.
Indrambarya T; Boyd JH; Wang Y; McConechy M; Walley KR
Crit Care; 2009; 13(3):R98. PubMed ID: 19549333
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock.
Luckner G; Mayr VD; Jochberger S; Wenzel V; Ulmer H; Hasibeder WR; Dünser MW
Crit Care Med; 2007 Oct; 35(10):2280-5. PubMed ID: 17944015
[TBL] [Abstract][Full Text] [Related]
14. Endocrinologic response to vasopressin infusion in advanced vasodilatory shock.
Dünser MW; Hasibeder WR; Wenzel V; Schwarz S; Ulmer H; Knotzer H; Pajk W; Friesenecker BE; Mayr AJ
Crit Care Med; 2004 Jun; 32(6):1266-71. PubMed ID: 15187504
[TBL] [Abstract][Full Text] [Related]
15. Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation.
Argenziano M; Chen JM; Cullinane S; Choudhri AF; Rose EA; Smith CR; Edwards NM; Landry DW; Oz MC
J Heart Lung Transplant; 1999 Aug; 18(8):814-7. PubMed ID: 10512533
[TBL] [Abstract][Full Text] [Related]
16. Arginine-vasopressin in neonates with vasodilatory shock after cardiopulmonary bypass.
Lechner E; Hofer A; Mair R; Moosbauer W; Sames-Dolzer E; Tulzer G
Eur J Pediatr; 2007 Dec; 166(12):1221-7. PubMed ID: 17225160
[TBL] [Abstract][Full Text] [Related]
17. Management of vasodilatory shock: defining the role of arginine vasopressin.
Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
[TBL] [Abstract][Full Text] [Related]
18. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
Westphal M; Stubbe H; Sielenkämper AW; Ball C; Van Aken H; Borgulya R; Bone HG
Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625
[TBL] [Abstract][Full Text] [Related]
19. Low-dose vasopressin infusion therapy for refractory hypotension in ELBW infants.
Ikegami H; Funato M; Tamai H; Wada H; Nabetani M; Nishihara M
Pediatr Int; 2010 Jun; 52(3):368-73. PubMed ID: 19793209
[TBL] [Abstract][Full Text] [Related]
20. Cardiac performance during vasopressin infusion in postcardiotomy shock.
Dünser MW; Mayr AJ; Stallinger A; Ulmer H; Ritsch N; Knotzer H; Pajk W; Mutz NJ; Hasibeder WR
Intensive Care Med; 2002 Jun; 28(6):746-51. PubMed ID: 12107681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
